Captopril in hypertensive emergencies. 1981

T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005260 Female Females
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
January 1993, Indian heart journal,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
February 1989, Cardiologia (Rome, Italy),
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
August 1992, Archives of internal medicine,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
February 1990, Japanese journal of pharmacology,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
October 1988, Zhonghua xin xue guan bing za zhi,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
June 1989, Arquivos brasileiros de cardiologia,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
January 1993, Nephron,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
March 1988, The American journal of medicine,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
January 1984, Arquivos brasileiros de cardiologia,
T Sakano, and N Okuda, and N Sakura, and H Yahata, and Y Tabe, and S Eno, and H Kurogane, and T Usui
September 1985, Lancet (London, England),
Copied contents to your clipboard!